RDD Pharma is a clinical stage company that is addressing an overlooked therapeutic area of lower gastrointestinal (GI) diseases. The company has two programs with a Phase 3 Ready molecule in Anal Fissure and an ongoing Phase 2a molecule in Fecal Incontinence. Both programs utilize an accelerated 50…
RDD Pharma is a clinical stage company that is addressing an overlooked therapeutic area of lower gastrointestinal (GI) diseases. The company has two programs with a Phase 3 Ready molecule in Anal Fissure and an ongoing Phase 2a molecule in Fecal Incontinence. Both programs utilize an accelerated 505(b)2 regulatory path and address a meaningful, high, unmet medical need.
RDD is privately held and VC backed (OrbiMed).
Team (1)
Sectors RDD Pharma serves:
Life Sciences
Join Axial's Private M&A Platform
RDD Pharma connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
